Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources
DCP Consortia for Early Phase Trials

Step 2: Conducting a Cancer Prevention Clinical Trial

These documents are intended for the use of the DCP Consortia staff conducting cancer chemoprevention studies under contract with the NCI/DCP.

SOP #5 Reporting and Tracking Serious Adverse Events

Responsibilities (SOP) (doc, 69kb)
Lists the Consortia responsibilities during reporting and tracking of SAEs.

Checklists/Documents

DCP Serious Adverse Event Form (doc, 80kb)
Use to report and track Serious Adverse Events (SAEs).

Serious Adverse Event Form Instructions for Completion (doc, 135kb)
Use as a reference to complete the DCP Serious Adverse Event Form.

Summary of Reporting Responsibility for Serious Adverse Events (SAEs) (doc, 41kb)
Use as a reference to review SAE reporting responsibilities for CLO and Participating Organization staff.